Speaker(s): 

Abigail Valente, PharmD. Candidate, Wilkes University - has nothing to disclose

Julia Iskra, Candidate, Wilkes University - has nothing to disclose.

Moderator(s): 

Christopher DeFrancesco, PharmD., Geisinger; Faith Wellings PharmD., Wilkes University - have nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: Julia Iskra, PharmD

• Review pathophysiology and pharmacologic treatment of asthma and chronic obstructive pulmonary disease (COPD)
• Discuss pertinent updates to Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None